TRT and Leydig Cell Function: The Testicular Impact
Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM
Testosterone Replacement Therapy (TRT) directly suppresses the function of Leydig cells in the testes, which are responsible for producing natural testosterone. This suppression occurs due to the negative feedback on Luteinizing Hormone (LH) and can lead to reduced endogenous testosterone production and testicular atrophy.
TRT and Leydig Cell Function: The Testicular Impact
Leydig cells are the unsung heroes of male endocrine health. Located within the testes, these specialized cells are the primary producers of testosterone in men, responsible for approximately 95% of your body's natural supply. Their activity is meticulously regulated by Luteinizing Hormone (LH), a signal from the pituitary gland. When you begin Testosterone Replacement Therapy (TRT), you're essentially introducing an external source of testosterone, which profoundly impacts the delicate balance governing Leydig cell function.
The introduction of exogenous testosterone triggers a negative feedback loop within the hypothalamic-pituitary-gonadal (HPG) axis. Your brain, sensing adequate testosterone levels, reduces its output of Gonadotropin-Releasing Hormone (GnRH) from the hypothalamus and, consequently, LH from the pituitary. This reduction in LH is the direct cause of Leydig cell suppression. Without their primary stimulant, these cells become quiescent, leading to a significant decrease in their activity and endogenous testosterone production.
The Mechanism of Leydig Cell Suppression
The suppression of Leydig cell function by TRT is a well-documented physiological response. Studies have shown that exogenous testosterone leads to a rapid decline in LH levels, which in turn diminishes the stimulation of Leydig cells [1]. This reduction in stimulation causes the Leydig cells to become less active, reducing their size and their capacity to produce testosterone. This is a key reason why men on TRT often experience testicular atrophy, as the testes, no longer needing to produce their own testosterone, decrease in overall volume.
It's important to understand that this isn't a permanent damage to the Leydig cells themselves, but rather a state of functional dormancy. If TRT is discontinued, and the HPG axis eventually recovers, Leydig cells can regain their function and resume testosterone production. However, the recovery period can be prolonged and varies significantly among individuals.
Nuances and Strategies for Preservation
For many men on TRT, the suppression of Leydig cell function is an acceptable trade-off for the benefits of optimized testosterone levels. However, for those concerned with maintaining testicular size, endogenous testosterone production, or fertility, preserving Leydig cell function becomes a priority. This is where adjunctive therapies like Human Chorionic Gonadotropin (HCG) come into play.
HCG acts as an LH analog, directly stimulating the Leydig cells to produce testosterone, even when the pituitary's own LH production is suppressed by TRT [2]. By administering HCG, typically at doses of 250-500mcg subcutaneously twice weekly, you can bypass the suppressed pituitary signal and keep the Leydig cells active. This helps to maintain intratesticular testosterone levels, preserve testicular size, and support spermatogenesis, which is highly dependent on a high local concentration of testosterone.
Comparison: Leydig Cell Activity with and without HCG on TRT
| Condition | LH Stimulation | Leydig Cell Activity | Endogenous Testosterone Production |
|---|---|---|---|
| Healthy Male (No TRT) | Active (pulsatile LH) | Active | High |
| On TRT (No HCG) | Suppressed | Quiescent | Minimal to none |
| On TRT (With HCG) | Suppressed (pituitary), Stimulated (by HCG) | Active (due to HCG) | Maintained |
Practical Takeaway
TRT will suppress your Leydig cells, leading to a halt in your natural testosterone production and potential testicular atrophy. If preserving Leydig cell function, testicular size, or fertility is important to you, discuss the use of HCG with your practitioner. It can help maintain the activity of these crucial cells despite TRT.
References
- Chung, J. Y., et al. (2019). Effects of pharmacologically induced Leydig cell testosterone suppression on spermatogenesis. Translational Andrology and Urology, 8(4), 373â381.
- Højer, E. G., et al. (2022). Effect of Testosterone Replacement Therapy on Quality of Life in Testicular Cancer Survivors with Mild Leydig Cell Insufficiency. The Journal of Sexual Medicine, 19(4), 607-616.